CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 112 enrolled
Drug / intervention
Ketorolac Dosedrug
Likely dose
Ketorolac Dose 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02181426
NCT02181426N/ACompleted
CompareCT.gov

Dose Response of Ketorolac in Out-Patients Undergoing Knee Arthroscopy

Medical University of South Carolina·interventional·Posted Jul 4, 2014·Updated Sep 21, 2018

In Brief

A clinical study evaluating Ketorolac Dose for Meniscectomy. Completed, enrolled 112 participants across 1 site.

Detailed Summary

Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMeniscectomy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 4, 2014
Enrollment StartMar 1, 2012
Primary CompletionDec 15, 2016
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 12.0 years ago

Interventions

Ketorolac Dosedrug

Subjects will be assigned an enrollment number. Enrollment numbers will be assigned consecutively in the order of study enrollment. Based on the enrollment number, subjects will be randomized by a pre-determined computer randomization list created by a statistician to receive a ketorolac dose (0, 7.5, 15, 30 mg).